CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-04 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +2,686 | 84,831 | ||
| 2022-03-04 | Taylor Ian Chief Scientific Officer | Sale | −869 | $63.94 | $56K | 83,962 |
| 2022-03-04 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −2,686 | 2,685 | ||
| 2022-03-04 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +4,791 | 163,040 | ||
| 2022-03-04 | Cassidy Sean A Chief Financial Officer | Sale | −1,593 | $63.94 | $102K | 161,447 |
| 2022-03-04 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,791 | 4,791 | ||
| 2022-03-04 | Houston John G President and CEO | Exercise or conversion | +17,511 | 849,844 | ||
| 2022-03-04 | Houston John G President and CEO | Sale | −6,024 | $63.94 | $385K | 843,820 |
| 2022-03-04 | Houston John G President and CEO | Exercise or conversion · Restricted Stock Units | −17,511 | 17,510 | ||
| 2022-03-01 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +3,500 | $16.00 | $56K | 82,145 |
| 2022-03-01 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −596 | 0 | ||
| 2022-03-01 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −925 | 13,872 | ||
| 2022-03-01 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −1,979 | 6,964 | ||
| 2022-02-23 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2022-02-23 | Cassidy Sean A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2022-02-23 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2022-02-23 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +200,500 | 200,500 | ||
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +20,000 | $19.36 | $387K | 98,645 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −5,867 | $71.74 | $421K | 92,778 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −5,766 | $72.55 | $418K | 87,012 |
Page 11 of 32 · 628 trades